Drug discovery is rapidly moving beyond the traditional immortalised cell lines into advanced models that can better mimic and predict the complex physiological environment of the human body. Organoids and spheroids have the potential to revolutionise drug discovery and toxicology by offering more predictive, human-relevant insights. This forum brings together experts from academia, biotech, and pharma to explore the latest advancements in physiologically relevant cell models, and how they are being adopted in practical applications. The event will highlight developments in organoid, organ on a chip technology, automation, and high-throughput screening, with discussions on their applications in disease modelling and safety assessment.

Join us at this one-day ELRIG forum to reflect on the challenges and opportunities of integrating these advanced models into the drug development pipeline. Researchers from industry and academia will share real-world case studies on improving drug candidate selection, reducing late-stage failures, and enhancing the predictive power of preclinical testing.